ASO Author Reflections: Active Surveillance for Ductal Carcinoma In Situ (DCIS)

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Hwang ES, Malek V. Estimating the magnitude of clinical benefit of local therapy in patients with DCIS. Breast. 2019;48 Suppl 1:S34–8. https://doi.org/10.1016/s0960-9776(19)31120-8.

    Article  PubMed  Google Scholar 

  2. 2.

    Oseni TO, Smith BL, Lehman CD, Vijapura CA, Pinnamaneni N, Bahl M. Do eligibility criteria for ductal carcinoma in situ (DCIS) active surveillance trials identify patients at low risk for upgrade to invasive carcinoma? Ann Surg Oncol. Epub 16 May 2020. https://doi.org/10.1245/s10434-020-08576-6.

  3. 3.

    Soumian S, Verghese ET, Booth M, et al. Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low-Risk DCIS Trial (LORIS). Eur J Surg Oncol. 2013;39(12):1337–40. https://doi.org/10.1016/j.ejso.2013.09.028.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Pilewskie M, Stempel M, Rosenfeld H, Eaton A, Van Zee KJ, Morrow M. Do LORIS trial eligibility criteria identify a ductal carcinoma in situ patient population at low risk of upgrade to invasive carcinoma? Ann Surg Oncol. 2016;23(11):3487–93. https://doi.org/10.1245/s10434-016-5268-2.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Grimm LJ, Ryser MD, Partridge AH, et al. Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials. Ann Surg Oncol. 2017;24(12):3534–40. https://doi.org/10.1245/s10434-017-6018-9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the Agfa HealthCare/Radiological Society of North America (RSNA) Research Scholar Grant (Principal Investigator (PI): Dr. Manisha Bahl) and the Electronic Space Systems Corporation (ESSCO)-MGH Breast Cancer Research Fund (PI: Dr. Manisha Bahl and Dr. Tawakalitu O. Oseni).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Manisha Bahl MD, MPH.

Ethics declarations

Disclosure

Tawakalitu O. Oseni and Manisha Bahl have no disclosures to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Oseni, T.O., Bahl, M. ASO Author Reflections: Active Surveillance for Ductal Carcinoma In Situ (DCIS). Ann Surg Oncol 27, 4466–4467 (2020). https://doi.org/10.1245/s10434-020-08637-w

Download citation